Paper
7 August 2019 Photodynamic therapy activity of new porphyrin-xylan-coated silica nanoparticles in a human colorectal cancer in vivo model
Author Affiliations +
Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 110709A (2019) https://doi.org/10.1117/12.2525033
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States
Abstract
Photodynamic therapy (PDT) using porphyrins has been approved in treatment of several solid tumors thanks to generation of cytotoxic reactive oxygen species (ROS). However, low physiological solubility and lack of selectivity towards tumors sites are the main limitations of their clinical use. Nanoparticles are able to spontaneously accumulate in solid tumors through the enhanced permeability and retention (EPR) effect due to leaky vasculature, poor lymphatic drainage and increased vessel permeability. Herein, we demonstrated added value of nanoparticles vectorization strategy on anticancer efficacy of the 5-(4-hydroxyphenyl)-10,15,20-triphenylporphyrin (TPPOH). Using the 80 nm silica nanoparticles (SNPs) coated with xylan-TPPOH conjugate (TPPOH-X), we highlighted on HT-29 tumor-bearing nude mice, a high anticancer efficacy of TPPOH-X SNPs compared to TPPOH free.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
L. Bretin, D.-Y. Leger, A. Pinon, S. Bouramtane, F. Bregier, V. Sol, V. Chaleix, and B. Liagre "Photodynamic therapy activity of new porphyrin-xylan-coated silica nanoparticles in a human colorectal cancer in vivo model", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110709A (7 August 2019); https://doi.org/10.1117/12.2525033
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Photodynamic therapy

Nanoparticles

In vivo imaging

Silica

Colorectal cancer

Cancer

Back to Top